BCM
LUXAU

BlueCrest Capital Management’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

BlueCrest Capital Management’s Portfolio LUXAU Stock Details LUXAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,250,000
Closed -$12.8M – 544
2021
Q2 		$12.8M Hold
1,250,000
– – 0.24% 80
2021
Q1 		$13.4M Hold
1,250,000
– – 0.22% 90
2020
Q4 		$14.4M Buy
+1,250,000
New +$13.4M 0.32% 79

Other funds holding LUXAU

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlueCrest Capital Management's LUXAU Position: Q3 2021 in Review

BlueCrest Capital Management sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q3 2021, closing a stake of 1,250,000 shares — an estimated $12.8M sold.

BlueCrest Capital Management first reported a position in LUXAU in Q4 2020 and held it in 3 quarters. The position peaked at $14.4M in Q4 2020. 15 funds tracked by Wall St. Rank hold LUXAU as of Q3 2021.

  • BlueCrest Capital Management reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q3 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,250,000 Lux Health Tech Acquisition Corp. Units shares in Q3 2021, an estimated $12.8M.
  • BlueCrest Capital Management first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 3 quarters.
  • BlueCrest Capital Management's Lux Health Tech Acquisition Corp. Units position peaked at $14.4M in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q3 2021.

Based on BlueCrest Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.